Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Xerostomia 1Tongue Neoplasms 1Sexuality 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 9Cetuximab 9Radiotherapy, Intensity-Modulated 6Sirolimus 2Platinum 2Fluorouracil 2Docetaxel 2Bevacizumab 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2temsirolimus 1sargramostim 1saracatinib 1dehydroftorafur 1adavosertib 1Vorinostat 1Trioxsalen 1Tobacco Use Cessation Devices 1Soybean Proteins 1Sorafenib 1Salts 1Pilocarpine 1Phototherapy 1Photochemotherapy 1Paclitaxel 1NVP-BKM120 1Moxibustion 1Irinotecan 1Immunoglobulin G 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Tongue Neoplasms × Pilocarpine × Clear all
NCT00656513 2019-11-19

Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 2/3 Completed
196 enrolled 13 charts
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Xerostomia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡